Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
Zhuangzhuang Zhang(University of Kentucky), Xiaoqi Liu(Indiana University Health), Qi Qiao(University of Kentucky), Nadia A. Lanman(Purdue University West Lafayette), Derek B. Allison(University of Kentucky), Lijun Cheng(The Ohio State University), Nuha Shaker(University of California, San Francisco), Anju Karki(Purdue University West Lafayette), B. Mark Evers(University of Kentucky), Kunyu Li(University of Kentucky), Qing Shao(Newman University), Xiongjian Rao(University of Kentucky), Daheng He(University of Kentucky), Sagar M. Utturkar(Purdue University West Lafayette), Chi Wang(Markey Cancer Center), Jie Li(Purdue University West Lafayette), Piotr Rychahou(Markey Cancer Center), Stephen F. Konieczny(Purdue University West Lafayette)
Cited by 68
Related Papers
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
|Cancer Research|2011|539
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
|The American Journal of Human Genetics|2010|394
Transcriptome and epigenome landscape of human cortical development modeled in organoids
|Science|2018|314
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
|BMC Genomics|2016|228
Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia
|American Journal Of Pathology|2007|210